Login
$SEER
$1.48 -$0.09 (5.73%) Live

$SEER SEC Filings

Filed On Filing
10 Nov 2026 10-Q
10 Nov 2026 8-K: Results of Operations and Financial Condition

REDWOOD CITY, Calif. – November 10, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended September 30, ...

04 Nov 2026 Form 4: Endweiss Charles, VP Financial Planning Analysis

Received 35,000 shares as a grant or award · Granted 65,000 Employee Stock Option (right to buy)

02 Nov 2026 SCHEDULE 13D
29 Oct 2026 8-K: Other Events

REDWOOD CITY, Calif., October 29, 2026 – Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors (the “Special Committee”) ...

08 Oct 2026 Form 3: Endweiss Charles, VP Financial Planning Analysis

Holds 107,641 shares of Common Stock

18 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

19 Aug 2026 Form 4: Horn David R., PRESIDENT & CFO

Sold 7,309 shares ($14.8K)

11 Aug 2026 10-Q
11 Aug 2026 8-K: Results of Operations and Financial Condition

REDWOOD CITY, Calif. – August 11, 2026 – Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for the quarter ended June 30, 2026.

31 Jul 2026 8-K: Submission of Matters to a Vote of Security Holders

Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge Parkway, Redwood City, CA 94065

31 Jul 2026 8-K: Other Events

Omid Farokhzad, M.D.Chief Executive OfficerSeer, Inc.3800 Bridge ParkwayRedwood City, CA 94065

30 Jul 2026 Form 4: Roelofs Nicolas H Phd, Director

Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy)

30 Jul 2026 Form 4: Ro Isaac, Director

Received 12,375 shares as a grant or award · Granted 18,750 Stock Option (right to buy)

30 Jul 2026 Form 4: Nishar Dipchand, Director

Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy)

30 Jul 2026 Form 4: Mcguire Terrance, Director

Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy)

30 Jul 2026 Form 4: Langer Robert, Director

Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy)

30 Jul 2026 Form 4: Gulyani Meeta, Director

Received 16,500 shares as a grant or award · Granted 25,000 Stock Option (right to buy)

28 Jul 2026 DFAN14A
24 Jul 2026 DFAN14A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support